首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1593484

血液培养测试市场规模、份额和成长分析（按技术、应用、最终用途和地区）：产业预测（2024-2031）

Blood Culture Tests Market Size, Share, Growth Analysis, By Technique (Conventional, Automated), By Application (Bacterial Infections, Fungal Infections), By End Use (Hospital Laboratories, Reference Laboratories), By Region -Industry Forecast 2024-2031

出版日期: 2024年11月08日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球血液培养检测市场规模估值为61.6亿美元，从2023年的69.2亿美元成长到2031年的175亿美元，在预测期间（2024-2031）预计复合年增长率为12.3% 。

由于血流感染疾病(BSI) 创新诊断产品的核准不断增加以及 BSI 盛行率不断上升，全球血液培养检测市场正经历显着成长。血液培养测试对于识别血液中的有害微生物（例如细菌和真菌）非常重要。此诊断程序包括提取血液样本并在无菌环境中培养，以促进这些病原体的生长，从而识别可能导致败血症等严重的感染疾病。及时、准确的检测结果对于指南医疗保健专业人员制定有针对性的抗生素治疗、改善患者照护、减少感染疾病传播和改善康復结果至关重要。此类检测的需求量很大，因为它们在有效的感染控制中发挥着至关重要的作用。

市场概况
消耗品
血培养基
有氧血培养基
儿科需氧血培养基
厌氧血培养基
结核分枝桿菌血培养基
真菌/酵母血培养基
检测试剂套件/试剂
血液培养配件
装置
全自动血液培养系统
实验室设备支援
培养箱
菌落计数器
显微镜
革兰氏染色设备
软体服务

全球血液培养检测市场规模（按技术）/复合年增长率（2024-2031）

市场概况
基于文化的技术
分子技术
微阵列
PCR（聚合酵素链锁反应）
PNA-FiSH（胜胜肽核酸-萤光杂合反应）
蛋白质体学技术

全球血液培养检测市场规模（按应用）/复合年增长率（2024-2031）

市场概况
菌血症
真菌血症
结核分枝桿菌检测

全球血液培养检测市场规模（依最终用户）/复合年增长率（2024-2031）

市场概况
医院实验室
参考实验室
学术实验室
其他考场

全球血液培养检测市场规模/复合年增长率（2024-2031）

北美（依方法、产品、技术、应用、最终用户）
- 美国
- 加拿大
欧洲（依方法、产品、技术、应用程式、最终用户）
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家
亚太地区（依方法、产品、技术、应用、最终用户）
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲（依方法、产品、技术、应用、最终用户）
- 巴西
- 其他拉丁美洲
中东/非洲（依方法、产品、技术、应用、最终用户）
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

雅培（美国）
F. Hoffmann-La Roche Ltd（瑞士）
诺华公司（瑞士）
礼来公司（美国）
默克公司（美国）
赛默飞世尔科技公司（美国）
西门子（德国）
丹纳赫公司（美国）
ZEPTOMETRIX（美国）
CytoTest Inc.（美国）
德维瑟（瑞典）
布鲁克（美国）
生物梅里埃（法国）
拜耳公司（德国）
BD（美国）

结论和建议

简介目录

Product Code: SQMIG35D2281

Global Blood Culture Tests Market size was valued at USD 6.16 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 17.50 billion by 2031, growing at a CAGR of 12.3% during the forecast period (2024-2031).

The global blood culture tests market is experiencing significant growth driven by the increasing approval of innovative diagnostic products for bloodstream infections (BSIs) and the rising prevalence of BSIs. Blood culture tests are critical in identifying harmful microorganisms such as bacteria or fungi in the bloodstream. This diagnostic procedure involves extracting a blood sample and cultivating it in a sterile environment to promote the growth of these pathogens, enabling the identification of infections that may lead to severe conditions like sepsis. Timely and accurate results are essential for guiding medical professionals in prescribing targeted antimicrobial treatments, improving patient care, reducing the spread of infections, and enhancing recovery outcomes. The demand for such tests is rising due to their crucial role in effective infection management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Culture Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Culture Tests Market Segmental Analysis

Global Blood Culture Tests Market is segmented based on the Method, Product, Technology, Application, End-Use, and Region. Based on Product, the market is segmented into Conventional/Manual Methods, Automated Methods. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Technology, the market is segmented into Culture-based Technology, Molecular Technology, Proteomics Technology. Based on Application, the market is segmented into Bacteremia, Fungemia, Mycobacterial Detection. Based on End Use, the market is segmented into Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Culture Tests Market

The rising global prevalence of bloodstream infections has significantly driven the demand for accurate and swift diagnostic solutions like blood culture tests. A 2023 World Health Organization report highlighted a notable rise in sepsis cases worldwide, underscoring the critical role of timely diagnosis in implementing effective treatment strategies. This growing urgency has led to increased investments in cutting-edge blood culture technologies, fueling advancements in the diagnostic solutions market aimed at combating infectious diseases. As a result, the blood culture tests market is experiencing accelerated growth, driven by the need for enhanced diagnostic accuracy and speed in addressing these life-threatening infections.

Restraints in the Global Blood Culture Tests Market

A significant restraint in the global blood culture tests market is the difficulty in interpreting blood culture results. Distinguishing between contaminants and clinically relevant pathogens requires specialized expertise, which can limit market growth by increasing reliance on skilled professionals and raising concerns about the accuracy of results. While improving training for medical personnel and enhancing reporting systems can help address these challenges, they do not fully resolve the complexities involved in interpreting the outcomes. This ongoing issue could hinder the widespread adoption and effectiveness of blood culture tests, as healthcare providers remain cautious about their reliability in diagnosing infections.

Market Trends of the Global Blood Culture Tests Market

One key trend in the global blood culture tests market is the growing emphasis on medical education and training programs. These initiatives are playing a pivotal role in raising awareness among healthcare professionals about the significant benefits of blood culture tests, particularly in the early and accurate diagnosis of sepsis. Workshops and seminars dedicated to sepsis management are becoming increasingly common, helping to underline the importance of timely blood culture testing. As awareness increases, it leads to improved patient care and creates crucial growth opportunities for the market. This heightened focus on education is driving the adoption of blood culture tests, further expanding their role in clinical settings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Pricing Analysis

Global Blood Culture Tests Market Size by Method & CAGR (2024-2031)

Market Overview
Conventional/Manual Methods
Automated Methods

Global Blood Culture Tests Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Blood Culture Media
Aerobic Blood Culture Media
Pediatric Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Mycobacterial Blood Culture Media
Fungi/Yeast Blood Culture Media
Assay Kits & Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Service

Global Blood Culture Tests Market Size by Technology & CAGR (2024-2031)

Market Overview
Culture-Based Technology
Molecular Technologies
Microarrays
PCR (Polymerase Chain Reaction)
PNA-FiSH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization)
Proteomics Technology

Global Blood Culture Tests Market Size by Application & CAGR (2024-2031)

Market Overview
Bacteremia
Fungemia
Mycobacterial Detection

Global Blood Culture Tests Market Size by End User & CAGR (2024-2031)

Market Overview
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories

Global Blood Culture Tests Market Size & CAGR (2024-2031)

North America, (Method, Product, Technology, Application, End User)
- US
- Canada
Europe, (Method, Product, Technology, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Method, Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Method, Product, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Method, Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEPTOMETRIX (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoTest Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devyser (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOMERIEUX (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments